Dr Reddy's Laboratories Faces Form 483 from USFDA
Dr Reddy's Laboratories Ltd's API facility in Bollaram, Hyderabad, received a Form 483 with seven observations after a USFDA inspection. The inspection took place from November 13-19, 2024, and the company plans to address the issues identified within the given timeline.
- Country:
- India
Dr Reddy's Laboratories Ltd has been issued a Form 483 with seven observations by the US health regulator following an inspection of its pharmaceutical manufacturing facility in Bollaram, Hyderabad.
The US Food & Drug Administration (USFDA) carried out the Good Manufacturing Practice (GMP) inspection from November 13 to 19, 2024. At the conclusion of the inspection, the USFDA presented the Form 483 outlining potential violations.
The company has committed to resolving the issues within the stipulated timeline set by the regulatory body.
(With inputs from agencies.)
- READ MORE ON:
- Dr Reddy's
- USFDA
- Form 483
- pharmaceutical
- inspection
- Bollaram
- Hyderabad
- GMP
- API
- regulatory
ALSO READ
Hyderabad Police Enforce 'Zero Drugs' Policy for New Year Celebrations
Bomb Scare in Chandigarh Court: Swift Evacuation and Inspection Ensures Safety
Hyderabad emerges as mega city with merger of 27 municipalities into GHMC
Hyderabad Police Enforce 'Zero Drugs Policy' for Safe New Year Celebrations
Delhi Government Streamlines Food Safety Inspections Ahead of New Year
Google News